MS News & Perspectives

FDA OKs Phase 3 Trial of Masitinib & New Year Hopes


Listen Later

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a masitinib trial that is expected to include up to 800 participants at about 75 sites in Europe, North America, Israel, and Africa.

He also reads “This New Year, I Resolve to Let Myself Hope” by Benjamin Hofmeister, from his column “Chairborne.”

===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
...more
View all episodesView all episodes
Download on the App Store

MS News & PerspectivesBy MS News Today

  • 4.4
  • 4.4
  • 4.4
  • 4.4
  • 4.4

4.4

8 ratings


More shows like MS News & Perspectives

View all
The Diary Of A CEO with Steven Bartlett by DOAC

The Diary Of A CEO with Steven Bartlett

8,485 Listeners